In July, Pfizer announced it is advancing development of a once-daily formulation of the oral GLP-1 receptor agonist danuglipron
This is especially important for patients who will be getting regional anesthesia, such as a spinal block or epidural
We have answers to the most popular questions from our customers
Having appropriate foods readily available means you will not need to venture out shopping while feeling under the weather, nor will you be left struggling to find something you can tolerate eating
On average, trial patients lost 8.6% to 12.6% of their body weight, or 19.8 to 29.3 pounds, after 26 weeks of taking orforglipron, compared to 2%, or 4.6 pounds, among those administered the placebo
Convenient Consumption: Can be taken without water by melting on the tongue or dissolved in a glass of water